当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3695191
自主品牌
已选条件
-
T62375SARS-CoV-2 nsp13-IN-3；化合物 SARS-CoV-2 nsp13-IN-3SARS-CoV-2 nsp13-IN-3
SARS-CoV-2 nsp13-IN-3 (Compound C3) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 32 μM).
价 格：￥电议型 号：T62375产 地：中国大陆
-
T62374Sarpogrelate；化合物 SarpogrelateSarpogrelate
Sarpogrelate (MCI-9042) is a new, orally active, specific 5-HT2 receptor antagonist. sarpogrelate increases platelet aggregation, has a haemostatic effect and can be used in the study of berghett´s disease.
价 格：￥电议型 号：T62374产 地：中国大陆
-
T62264SARS-CoV-2 nsp13-IN-2；化合物 SARS-CoV-2 nsp13-IN-2SARS-CoV-2 nsp13-IN-2
SARS-CoV-2 nsp13-IN-2 (Compound C2) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 42 μM).
价 格：￥电议型 号：T62264产 地：中国大陆
-
T62248SARS-CoV-2 nsp13-IN-6；化合物 SARS-CoV-2 nsp13-IN-6SARS-CoV-2 nsp13-IN-6
SARS-CoV-2 nsp13-IN-6 (compound C5) is a potent inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on ssDNA+ATPase (IC50: 27 μM) and ssDNA-ATPase (IC50: 33 μM). nsp13-IN-6 can be used in anti-COVID-19 studies.
价 格：￥电议型 号：T62248产 地：中国大陆
-
T6219Azilsartan Medoxomil；阿齐沙坦酯TAK-491；TAK-491|||阿齐沙坦酯
Azilsartan Medoxomil (TAK-491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension.
价 格：￥电议型 号：T6219产 地：中国大陆
-
T62031SARS-CoV-2 nsp13-IN-4；化合物 SARS-CoV-2 nsp13-IN-4SARS-CoV-2 nsp13-IN-4
SARS-CoV-2 nsp13-IN-4 (C4 (d)) is a potent and selective small-molecule inhibitor of nsp13 helicase. SARS-CoV-2 nsp13-IN-4 inhibits the ssDNA+ ATPase activity of nsp13 with an IC 50 of 57 μM. SARS-CoV-2 nsp13-IN-4 can provide a broad-spectrum antiviral effect.
价 格：￥电议型 号：T62031产 地：中国大陆
-
T61774SARS 3CLpro-IN-1；化合物 SARS 3CLpro-IN-1SARS 3CLpro-IN-1
SARS 3CLpro-IN-1 (Compound 3b) is a stereo-specific SARS 3CL protease inhibitor that belongs to the octahydroisochromene scaffold. It demonstrates inhibition against the P1 site imidazole, with an IC50 value of 95 μM [1].
价 格：￥电议型 号：T61774产 地：中国大陆
-
T61613SARS-CoV-2-IN-17；化合物 SARS-CoV-2-IN-17SARS-CoV-2-IN-17
SARS-CoV-2-IN-17 (Compound 16) is a highly effective inhibitor of SARS-CoV-2 nucleocapsid protein (NPro). It demonstrates potent anti-viral activity, with an EC50 value of 2.18 μM. Furthermore, SARS-CoV-2-IN-17 binds to NPro with a low Kd value of 7.82 μM, highlighting its potency as a NPro ligand [1].
价 格：￥电议型 号：T61613产 地：中国大陆
-
T61591SARS-CoV-2-IN-20；化合物 SARS-CoV-2-IN-20SARS-CoV-2-IN-20
SARS-CoV-2-IN-20 (Compound 1a) is a highly effective inhibitor of SARS-CoV-2, displaying an impressive EC50 value of 6.5 μM. With its exceptional inhibitory properties, SARS-CoV-2-IN-20 holds great potential for advancing research on infectious diseases [1].
价 格：￥电议型 号：T61591产 地：中国大陆
-
T6131Pimasertib；化合物PimasertibAS703026|||MSC1936369B|||SAR 245509；AS703026|||MSC1936369B|||N-[(2S)-2,3-二羟基
Pimasertib (AS703026) is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.
价 格：￥电议型 号：T6131产 地：中国大陆
-
T60962SARS-CoV-2-IN-18；化合物 SARS-CoV-2-IN-18SARS-CoV-2-IN-18
SARS-CoV-2-IN-18 (Compound 26) is a potent inhibitor of SARS-CoV-2 3C-like protease (IC50 = 45 nM) [1].
价 格：￥电议型 号：T60962产 地：中国大陆
-
T60919SARS-CoV-2-IN-13；化合物SARS-CoV-2-IN-13SARS-CoV-2-IN-13
SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 μM [1].
价 格：￥电议型 号：T60919产 地：中国大陆
-
T60908SARM1-IN-2；SARM1抑制剂2SARM1-IN-2
SARM1-IN-2 is a potent SARM1 inhibitor for the study of metabolic and neurological related diseases.
价 格：￥电议型 号：T60908产 地：中国大陆
-
T60861SARS-CoV-2 nsp3-IN-1；化合物 SARS-CoV-2 nsp3-IN-1SARS-CoV-2 nsp3-IN-1
SARS-CoV-2 nsp3-IN-1 (Compound 15c) shows significant selectivity for coronavirus macrodomains, especially SARS-CoV-2 Mac1. SARS-CoV-2 nsp3-IN-1 can inhibit Mac1 ADP-ribosylhydrolase activity that is an inhibitor of Mac1 (IC50 = 6.1 μM) [1].
价 格：￥电议型 号：T60861产 地：中国大陆
-
T60841SARS-CoV-2-IN-23；化合物 SARS-CoV-2-IN-23SARS-CoV-2-IN-23
SARS-CoV-2-IN-23 (compound GRL-0617) is an inhibitor of SARS-COV-2 papain-like protease (PLpro) (IC 50 = 2.3 μM) [1].
价 格：￥电议型 号：T60841产 地：中国大陆
-
T60818SARS-CoV-2-IN-15；化合物 SARS-CoV-2-IN-15SARS-CoV-2-IN-15
SARS-CoV-2-IN-15 (compound 11) is a niclosamide analogue that contains higher stability in human plasma and liver S9 enzymes assay than niclosamide. It improves bioavailability and half-life when administered orally. SARS-CoV-2-IN-15 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.49 μM [1].
价 格：￥电议型 号：T60818产 地：中国大陆
-
T60785SARS-CoV-2-IN-6；化合物 SARS-CoV-2-IN-6SARS-CoV-2-IN-6
SARS-CoV-2-IN-6 is an inhibitor of SARS-CoV-2 3CLpro with the IC 50 value of 73 nM.
价 格：￥电议型 号：T60785产 地：中国大陆
-
T6078Saracatinib；塞卡替尼AZD0530；AZD0530|||塞卡替尼
Saracatinib (AZD0530) (AZD0530) is an effective Src inhibitor (IC50: 2.7 nM), and effective to Lck, Fyn, Lyn, Blk, Fgr and c-Yes.
价 格：￥电议型 号：T6078产 地：中国大陆
-
T60686SARS-CoV-2 Mpro-IN-1；化合物 SARS-CoV-2 Mpro-IN-1SARS-CoV-2 Mpro-IN-1
SARS-CoV-2 Mpro-IN-1 (compound 16b-3) is a potent, selective and irreversible SARS-CoV-2 main protease (Mpro) inhibitor (IC 50 = 116 nM) [1].
价 格：￥电议型 号：T60686产 地：中国大陆
-
T60556SARS-CoV-2-IN-16；化合物 SARS-CoV-2-IN-16SARS-CoV-2-IN-16
SARS-CoV-2-IN-16 (Compound 12) is a potent inhibitor of SARS-CoV-2 nucleocapsid protein (NPro) with potent antiviral activity (EC50 = 3.69 μM). SARS-CoV-2-IN-16 binds to NPro with a low Kd value of 7.82 μM, which suggests that SARS-CoV-2-IN-16 is an effective NPro ligand [1].
价 格：￥电议型 号：T60556产 地：中国大陆
